Cellular immunity in people resistant to HCV infection.

被引:0
|
作者
Freeman, AJ [1 ]
Post, JJ [1 ]
Harvey, CE [1 ]
Pan, Y [1 ]
White, PA [1 ]
Marinos, G [1 ]
Rawlinson, WD [1 ]
Ffrench, R [1 ]
Lloyd, AR [1 ]
机构
[1] Univ New S Wales, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
401
引用
收藏
页码:263A / 263A
页数:1
相关论文
共 50 条
  • [41] Low virus heterogeneity is important for the spontaneous clearance of HCV infection.
    Peters, T
    Czerwinski, O
    Diepolder, H
    Pape, G
    Rasenack, J
    GASTROENTEROLOGY, 2000, 118 (04) : A1015 - A1015
  • [42] Bronchial asthma, another extrahepatic manifestation of chronic HCV infection.
    Ersoz, G
    Akarca, US
    Topalak, O
    Gunsar, F
    Karasu, Z
    Sayiner, A
    Batur, Y
    HEPATOLOGY, 1996, 24 (04) : 1523 - 1523
  • [43] Cost effectiveness of consensus interferon therapy for chronic HCV infection.
    McHutchison, JG
    Woolley, JM
    Nyberg, LM
    HEPATOLOGY, 1997, 26 (04) : 1172 - 1172
  • [44] Risk factors for the progression of chronic hepatitis C (HCV) infection.
    Rai, R
    Gruskin, L
    Nelson, K
    Vlahov, D
    Astemborski, J
    Thomas, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1363 - A1363
  • [45] Induction of Fas expression on human lymphoid cells by HCV infection.
    Taya, N
    Torimoto, Y
    Hirai, K
    Satoh, K
    Ohnishi, K
    Hasebe, C
    Kohgo, Y
    BLOOD, 1997, 90 (10) : 2976 - 2976
  • [46] Immunologic determinants of clinical autoimmune manifestations in chronic HCV infection.
    Vassilopoulos, D
    Younossi, ZM
    Hadziyannis, E
    Boparai, N
    Gramlich, T
    Yen-Lieberman, B
    Hsi, E
    Cook, D
    Ball, E
    Villa-Forte, A
    Calabrese, LH
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S367 - S367
  • [48] Virus Alert: a chairside system for evaluation of the risk of HCV infection.
    Gambarini, G
    Testarelli, L
    De Luca, M
    Castellini, F
    Dolci, G
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A263 - A263
  • [49] Chemokine and chemokine receptor polymorphisms and clinical outcomes of HCV infection.
    Promrat, K
    McDermott, D
    Gonzalez, C
    Lessie, M
    Merrell, M
    Kleiner, DE
    Koziol, D
    Soza, A
    Ghany, M
    Alter, H
    Hoofnagle, J
    Murphy, P
    Liang, TJ
    HEPATOLOGY, 2002, 36 (04) : 385A - 385A
  • [50] Determination of health utility measures in patients with chronic HCV infection.
    Sherman, KE
    Sherman, SN
    Chenier, T
    Tsevat, J
    HEPATOLOGY, 2000, 32 (04) : 424A - 424A